Publication | Open Access
Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy
50
Citations
27
References
2018
Year
ICAM/DEX/NLCs may represent a potential pulmonary endothelium targeted device, which facilitate translation of DEX into clinical ALI treatment.
| Year | Citations | |
|---|---|---|
2010 | 2.5K | |
2007 | 761 | |
2005 | 590 | |
2012 | 158 | |
2016 | 139 | |
2017 | 124 | |
2013 | 106 | |
2012 | 105 | |
2013 | 102 | |
2014 | 89 |
Page 1
Page 1